Novitium’s Pyridostigmine Shows Six Appeal Of CGT Pathway

 
• By Aidan Fry

In granting its sixth approval for an ANDA with a Competitive Generic Therapy (CGT) designation, the FDA insists it is fostering competition in the US off-patent market.

Eggs
US approvals under the newly created Competitive Generic Therapy (CGT) scheme have now hit the half-dozen mark • Source: Shutterstock

More from Products

More from Generics Bulletin